Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001477932-25-000832
Filing Date
2025-02-10
Accepted
2025-02-10 17:16:37
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A bglc_pre14a.htm PRE 14A 192552
  Complete submission text file 0001477932-25-000832.txt   193818
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41750 | Film No.: 25606687
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)